e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Biomarkers of asthma and COPD: recent advances
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Proteomic analysis of exhaled endogenous particles non-invasively sampled from the airways
A. Bredberg, J. Gobom, A. C. Almstrand, P. Larsson, A. C. Olin, E. Mirgorodskaya (Sweden)
Source:
Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Session:
Biomarkers of asthma and COPD: recent advances
Session type:
Oral Presentation
Number:
3840
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bredberg, J. Gobom, A. C. Almstrand, P. Larsson, A. C. Olin, E. Mirgorodskaya (Sweden). Proteomic analysis of exhaled endogenous particles non-invasively sampled from the airways. Eur Respir J 2010; 36: Suppl. 54, 3840
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Analysis of SpA in exhaled particles
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Year: 2010
Effects of concentrated ambient air particles (CAPs) on markers of airways inflammation in exhaled breath condensate of healthy volunteers
Source: Eur Respir J 2004; 24: Suppl. 48, 237s
Year: 2004
Airway cytokine expression measured by protein array in exhaled breath condensate: correlation with physiological properties in asthmatic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 444s
Year: 2006
Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
External validation of exhaled breath molecular profiling in identifying COPD and asthma
Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Year: 2010
Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011
Exhaled particles in healthy subjects and asthma patients – a new method for analysis of exhaled air
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Is NMR-based metabolomic analysis of exhaled breath condensate accurate?
Source: Eur Respir J 2011; 37: 468
Year: 2011
Differential measurement of exhaled breath temperature allows characterization of the spread of inflammation in airways diseases
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Year: 2010
A new approach for exhaled breath condensate analysis by calculating the release of mediators per minute, standardised for the total water vapour in exhaled air
Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases
Year: 2010
Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002
TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls
Source: Eur Respir J 2012; 39: 59-66
Year: 2012
TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls
Source: Eur Respir J 2011; 39: 59-66
Year: 2012
Comparison of mediator levels in exhaled breath condensate obtained through tracheostomy or orally
Source: Eur Respir J 2003; 22: Suppl. 45, 293s
Year: 2003
Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019
Phenotyping of COPD by integrated metabolomic profiling of exhaled breath condensate and peripheral blood
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification
Source: Eur Respir J 2007; 30: Suppl. 51, 364s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept